Gilead Sciences Inc buy BMO Capital Markets
Start price
16.05.23
/
50%
€73.00
Target price
16.05.24
€91.88
Performance (%)
-14.51%
End price
17.05.24
€62.41
Summary
This prediction ended on 17.05.24 with a price of €62.41. The price of Gilead Sciences Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.51%. Dividends of €2.79 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Gilead Sciences Inc | -0.240% | -0.240% | -14.415% |
| iShares Core DAX® | 0.051% | 5.593% | 14.403% |
| iShares Nasdaq 100 | 1.808% | 7.445% | 34.917% |
| iShares Nikkei 225® | 2.181% | 2.815% | 11.116% |
| iShares S&P 500 | 1.040% | 4.975% | 27.631% |
Comments by BMO_Capital_Markets for this prediction
In the thread Gilead Sciences Inc diskutieren
Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $100.00 price target on the stock, up previously from $90.00.
Ratings data for GILD provided by MarketBeat
In the thread Trading Gilead Sciences Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten